Treatment

Placebo for PRAX-628 clinical trials

2 indexed studies · 0 currently recruiting

Ongoing, recruitingPhase II and Phase III (Integrated)
A Double-Blind, Randomized, Multicenter, Trial Evaluating the Efficacy and Safety of PRAX-628 in Adults with Focal Seizures (POWER 1)
This study is testing a new medicine, PRAX-628, for adults with focal epilepsy. It compares PRAX-628 to a dummy pill to see if it reduces seizures and whether it's safe. It's a key step in understanding if this new treatment could help people with focal seizures.
For: Focal Epilepsy
Spain · Poland · Italy
Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2, Single-Blind, Placebo-Controlled, Fixed-Sequence Design Trial to Evaluate the Photoparoxysmal Electroencephalogram Response, Safety, Tolerability, and Pharmacokinetics of PRAX-628 in Participants with Epilepsy and a Photoparoxysmal Electroencephalogram Response to Intermittent Photic Stimulation
This study is testing a new medicine, PRAX-628, for people with epilepsy whose brains show certain changes when exposed to flashing lights. We want to see if the medicine can stop these brain changes and if it's safe to use.
For: IPS induced photoparoxysmal electroencephalogram response (IPS-induced PPR) in participants with epilepsy and IPS-induced PPR
Netherlands